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ABSTRACT
In humans, the lacrimal gland (LG) is the primary contributor to the aqueous layer of the tear film.
Production of tears in insufficient quantity or of inadequate quality may lead to aqueous-
deficiency dry eye (ADDE). Currently there is no cure for ADDE. The development of strategies to re-
liably isolate LG stem/progenitor cells from the LG tissue brings great promise for the design of cell
replacement therapies for patients with ADDE. We analyzed the therapeutic potential of epithelial
progenitor cells (EPCPs) isolated from adult wild-type mouse LGs by transplanting them into the
LGs of TSP-12/2 mice, which represent a novel mouse model for ADDE. TSP-12/2 mice are normal
at birth but progressively develop a chronic form of ocular surface disease, characterized by deteri-
oration, inflammation, and secretory dysfunction of the lacrimal gland. Our study shows that, among
c-kit-positive epithelial cell adhesion molecule (EpCAM+) populations sorted from mouse LGs, the
c-kit+dim/EpCAM+/Sca12/CD342/CD452 cells have thehallmarks of an epithelial cell progenitor pop-
ulation. Isolated EPCPs express pluripotency factors and markers of the epithelial cell lineage Runx1
and EpCAM, and they form acini and ducts when grown in reaggregated three-dimensional cultures.
Moreover,when transplanted into injured or “diseased” LGs, they engraft into acinar andductal com-
partments. EPCP-injected TSP-12/2 LGs showed reduction of cell infiltration, differentiation of the
donor EPCPs within secretory acini, and substantial improvement in LG structural integrity and func-
tion. This study provides the first evidence for the effective use of adult EPCP cell transplantation to
rescue LG dysfunction in a model system. STEM CELLS TRANSLATIONALMEDICINE 2016;5:1–11
SIGNIFICANCE
In humans, the lacrimal gland is the primary contributor to the aqueous layer of the tear film. Damage
or inflammation of the lacrimal glandmay lead to severe aqueous-deficiency dry eye and corneal dis-
ease. Endogenous lacrimal gland epithelial cell progenitors (EPCPs) injected into the gland of mouse
model of human Sjo¨gren’s syndrome TSP-12/2mice resulted in long-termengraftment andmarkedly
improved structure and function of “diseased” lacrimal gland. This study demonstrates, for the first
time, that EPCPs canmediate functional recovery of the lacrimal gland in a Sjo¨gren’s syndromemouse
model. These data establish proof of concept that endogenous stem/progenitor cell transplantation
may be used to treat human lacrimal gland chronic inflammation.
INTRODUCTION
Aqueous-deficiency dry eye (ADDE) is character-
ized by a lack of tear secretion from the lacrimal
glands (LGs). ADDE affects millions of Americans,
causing a debilitating loss of visual acuity, ocular
surface irritation, and adverse lifestyle changes.
In humans, the LGs are the primary contributor
to the aqueous layer of the tear film, and many
cases of ADDE, classified as aqueous surface dry
eye, involve LG dysfunction and/or degeneration.
Oneof the challenges of understanding themech-
anism of humandry eye pathogenesis is the inabil-
ity to perform biological and molecular studies
before obvious clinical signs. As a result, the pre-
cise steps of disease development are not well
understood. Currently there is no cure for ad-
vance cases of dry eye. Developing new thera-
pies to restore LG function would drastically
improve the quality of life of patients affected
by ADDE. One possible new treatment option
for ADDE is the use of stem/progenitor cells to
induce LG regeneration. In many tissues (lung,
muscle, brain, and heart), stem/progenitor cell-
based therapies have been demonstrated to be
viable approaches to treating diseases previously
considered incurable [1–3]. Similar to other exo-
crine glands (pancreas, salivary, and mammary)
[4–7], the “healthy” adult LG is highly regenerative
and is able to repair itself, even after substantial
damage [8, 9]. For example, a single injection of in-
terleukin-1a (IL-1a) inducesa severe inflammatory
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response, leading to destruction of LG acinar and epithelial cells,
followed by epithelial cell proliferation and complete LG regener-
ation. In contrast, “diseased” chronically inflamed LGs that also
show structural damage/destruction do not effectively repair
[10]. The reason for this failure to repair is unclear, but may relate
tochronic disruptionof LGstemcell niche functions that are impor-
tant to support stemcell-mediated regeneration. There is evidence
that the adult LG epithelium contains both slow-cycling stem cells
[11] and faster-cycling progenitor cells [12, 13]; however, the roles
of these cells in LG regeneration remain undefined.
Recently, replacement of an adult mouse LG with an embry-
onic LG-derived epithelio-mesenchymal reaggregate has been
demonstrated [9]. However, obtaining human embryonic LGs
would be a challenge, and they may not contain enough cells
for adult LG restoration.
In this study, we report the isolation and characterization of
putative epithelial cell progenitors (EPCPs) from adult uninjured
LGs. These cells expressed c-kit and markers of the epithelial cell
lineage Runt-related transcription factor 1 (Runx1) and epithelial
cell adhesion molecule (EpCAM). When grown in reaggregated
three-dimensional (3D) cultures, EPCPswere able to differentiate
into organoids containingmultiple LG cell types.Moreover, when
transplanted into injured LGs, EPCPs were able to engraft into ac-
inar and ductal compartments.
We also tested the engraftment and function of EPCPs in the
“diseased” LG using a recently reported model of ADDE—the
thrombospondin-1 null TSP-12/2 (also known as Thbs-12/2)
mouse. This model fully mimics the development of chronic au-
toimmune dry eye diseasewith loss of function preceding inflam-
matory cell infiltration [14]. Thrombospondin-1 is a component of
the extracellular matrix that functions in cell-matrix and cell-cell
interactions, regulation of cellular phenotype, and activation of
latent transforming growth factor-b [15, 16]. Although born with
no apparent abnormalities of the LG anterior segment, TSP-12/2
mice develop a severe inflammation of the LGwith inflammatory
infiltrates containing CD4 andCD8T cells. Similar to Sjo¨gren’s syn-
drome (SjS) patients, both anti-SSA/Ro and anti-SSB/La autoanti-
bodies are detected at elevated levels in TSP-12/2mice sera, and
a significant loss of LG secretory function is observed by 24weeks
[14]. Elevated levels of interleukins 17and6and interferong (IFN-
g) in the LG of 8-week-old TSP-12/2 mice are also observed.
Transplantation of EPCPs into a chronically inflamed LGof the
TSP-12/2mouse restored the structural compartmentof the “dis-
eased” LG and increased tear secretion. This study provides new
insight into LG progenitor cells that might be used in cell replace-
ment therapy for degenerative dry eye diseases that still have no
effective treatment.
MATERIALS AND METHODS
Mice
C57BL/6 (3–4weeksold)micewereused for LGEPCP isolationand
characterization. Donor and recipient mice were maintained in
The Scripps Research Institute (TSRI) vivarium under standard
conditions. Donor cells were isolated from Rosa26-LacZ (R26-
LacZ) or Pax6-LacZmice. R26-LacZmicewere generated by cross-
ingR26-CreandR26-LacZflox/floxmiceasdescribedpreviously [17].
The Pax6-LacZ mouse was reported previously [18]. Mice
used as recipients for EPCP transplantations were C57BL/6J
(wild-type) and TSP-12/2 mice that are a model of chronic
LG inflammation/destruction. TSP-12/2 mice were originally pur-
chased from the Jackson Laboratory (Sacramento, CA, https://
www.jax.org) andwerebredandmaintainedontheC57BL/6Jback-
ground at the Scripps Research Institute vivarium. All experiments
were conducted in accordancewith theAssociation for Research in
Vision and Ophthalmology Statement for the Use of Animals in
Ophthalmic andVisionResearchandwere approvedbyThe Scripps
Research Institute Animal Care and Use Committees.
Culture Media
Dissection Medium
Eagle’s Minimum Essential medium (MEM; catalog no. 12492-
013, Thermo Fisher Scientific Life Sciences, Oakwood Village,
OH, https://www.thermofisher.com)without glutaminewas sup-
plemented with the Glutamax at 5 ml (catalog no. 35050-061,
Thermo Fisher), 10% fetal bovine serum (FBS), and antibiotic-
antimycotic (catalog no. 15240-062, Thermo Fisher).
Growth Medium
EpiLife (Thermo Fisher) was supplemented with Human Corneal
Growth Supplement (catalog no. S-009-5, Thermo Fisher), 5 ng/
ml basic fibroblast growth factor (bFGF) (FGF2), 10 ng/ml epider-
mal growth factor (EGF) (R&D Systems Inc., Minneapolis, MN,
https://www.rndsystems.com), and 10% FBS.
Differentiation Medium
Fitton-Jackson Modification (BGJb) was supplemented with
GlutaMAX, 0.1%Lipid-RichBovine SerumAlbumin (AlbuMAX I, cat-
alog no. 11020, Thermo Fisher), insulin-transferrin-selenium (cata-
log no. 41400-045, Thermo Fisher), human transferrin (catalog no.
0030124SA, Thermo Fisher), and 5 ng/ml EGF (R&D Systems).
Immunostaining and Confocal Microscopy
LG sections, monolayer, and 3D cultures were stained by using an
indirect sequential immunoenzymatic technique. The following
primary antibodies were used for immunostaining: rabbit poly-
clonal antibody to Pax6 (PRB-278P, Covance, Princeton, NJ,
http://www.covance.com), mouse monoclonal E-cadherin anti-
body (clone 36/E-cadherin; catalog no. 610181, BD Biosciences,
San Jose, CA, http://www.bdbiosciences.com; or clone DECMA-
1; EMD Millipore, Billerica, MA, http://www.emdmillipore.com),
rat monoclonal antibody against Ser-28 phosphohistone-H3
(P-H3) (cloneHTA28; catalog no.H9908, Sigma-Aldrich, St. Louis,
MO,http://www.sigmaaldrich.com), lamininantibodyproduced in
rabbit (catalog no. L 9393; Sigma-Aldrich), and cytokeratin 5
(Krt5) rabbit polyclonal antibody (catalog no. AF138; Covance),
mousemonoclonala-smoothmuscle actin antibody (clone 1A4;
catalog no. A2547, Sigma-Aldrich), rat monoclonal antibody to
platelet endothelial cell adhesion molecule (CD31) (clone MEC
13.3; catalog no. 557355, BD Biosciences), goat polyclonal anti-
body to thrombospondin-1 (c-20; catalog no. sc-7653; Santa
Cruz Biotechnology Inc., Santa Cruz, CA, http://www.scbt.com).
Complimentarysecondaryantibodieswereobtained fromThermo
Fisher. Images were taken by using a Zeiss LSM 780 laser scanning
confocal microscope (Zeiss, Stuttgart, Germany, http://www.
zeiss.com).
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Western Blotting Analysis
Cultured undifferentiated and differentiated EPCPs were homog-
enized in radioimmunoprecipitation assay (RIPA) buffer and
sonicated. Equal aliquots of protein were resolved by SDS-
polyacrylamide gel electrophoresis, transferred to polyvinylidene
difluoride membrane, and probed with antibodies to Aquaporin-
5 (Aqp5; ab104751, Abcam, Cambridge, MA, http://www.abcam.
com) and reprobed with the b-actin antibody (clone AC-15,
A5441, Sigma-Aldrich) (loading control), which acted as a refer-
ence standard. The bands were quantified by densitometry,
and the ratio of Aqp5/b-actin was calculated. Three experiments
were performed, and the results were normalized to the values
from spontaneously differentiated EPCP cultures (48 hours in
the differentiation culture medium).
Lacrimal Gland Cell Dissociation (Adult Mouse
Uninjured Glands)
To obtain sufficient cells for flow cytometric analysis and
fluorescence-activated cell sorting (FACS), we pooled LGs from
6–12mice.Micewere euthanized, and the skinwas sterilizedwith
70% ethanol before surgically exposing the LG. The LG was dis-
sected away from the closely associated parotid salivary gland
and placed into phosphate-buffered saline (PBS), pH 7.4. The
LG capsule was removed with tweezers, and pooled LGs were
treated with trypsin-pancreatin solution [19] for 25–40 minutes
at room temperature to promote penetration of collagenase at
thenext step. LGswere rinsedwithdissectionmedium(MEMsup-
plemented with 10% FBS and antibiotic-antimycotic; catalog no.
15240-062, Thermo Fisher) and minced in 2 ml of 2 mg/ml colla-
genase (type I, Thermo Fisher Scientific Life Sciences catalog no.
17100-017) in dissection medium. LG fragments were incubated
in a CO2 incubator for 30–60 minutes with gentle triturating to
dissociate cells (timing varied by age group). Dissociated cells
were filtered through a 70-mm mesh cell strainer (catalog no.
352350, Corning Life Sciences DL, Kaiserslautern, Germany,
https://www.corning.com), washed in dissectionmedium, resus-
pended, and refiltered. Cells were treated for 15 minutes in a so-
lution of 100 mg/ml DNase I (Sigma-Aldrich, catalog no. D-4513)
and 5 mM MgCl2 in Hanks’ balanced saline solution (HBSS) at
room temperature. Finally, the isolated LG cells were resus-
pended in 5 ml of growth medium.
Antibody Staining and Fluorescence-Activated
Cell Sorting
To remove red blood cells, 25ml of cold red blood cell lysis buffer
(0.2% [wt/vol] Tris pH 7.5, 0.747% [wt/vol] NH4Cl) was added to
each tube of LG cells suspended in growth medium. Purified LG
cells were collected by centrifugation at 1,000g, resuspended
in 100 mg/ml DNase, 5 mM MgCl2 in HBSS (DNase, Sigma-
Aldrich D-4513; HBSS, Sigma H-6648) and incubated for 15–30
minutes at room temperature. The cells were pelleted at 1,000g,
washed in HBSS, resuspended in staining buffer PBE (13 PBS,
0.5% bovine serum albumin, 1 mM EDTA) and counted. For FACS
analysis, approximately 0.5 3 106 cells were pelleted at 1,200g
for 10minutes at 4°C and resuspended in 100ml of staining buffer
with the appropriate conjugated antibody. The following anti-
bodies were used: phycoerythrin (PE) rat anti-mouse Ly-6A/E
(Sca1) (catalog no. 553336, BD Biosciences); PE-Cy7 rat anti-
mouse CD31 (catalog no. 561410, BD Biosciences); FITC rat anti-
mouse CD34 (catalog no. 553733, BD Biosciences); anti-mouse
CD117 (c-Kit) allophycocyanin (APC)-eFluor 780 (catalog no. 47-
1171-80, eBioscience, San Diego, CA, http://www.ebioscience.
com); and anti-mouse CD326 (EpCAM) APC (catalog no. 17-5791-
80,eBioscience).Thecellswerestainedonice for1hourwithgentle
vortexing every 15–20 minutes, pelleted as above, and resus-
pended in 1 ml of cold PBE in FACS tubes.
Flow cytometric analysis and FACS were performed at the
TSRI Flow Cytometry Core Facility by using Digital LSRII and FACS
Vantage DiVa instruments. Data analyses were performed by us-
ing FlowJo software. Themainpopulation of cellswasdetermined
by forward and side scatter area gating, as well as dead cell exclu-
sion via propidium iodide or 7-aminoactinomycin D. Doublets
were excluded via forward scatter area versuswidth andwith side
scatter area versus width (supplemental online Fig. 1A, 1B). Con-
trol samples labeled with isotype control antibodies and with a
single primary antibody were used to determine the background
noise because of nonspecific antibody binding and to establish
proper compensation for optimum separation between signals.
Preparation of 3D Reaggregated EPCP Cultures
EPCPs were isolated by FACS as described above. Isolated EPCPs
were counted and dissociated in culture medium. A total of 13
105 to 1.53106 cells in 50ml ofmediumweredrawn into a 100-ml
pipette tip, and the tipwas sealedwith sterile parafilm. Cellswere
pelleted at 1,000g for 10 minutes and the cell plug/reaggregate
then was inoculated into a 15-ml drop of laminin-111 (Trevigen,
Gaithersburg, MD, https://www.trevigen.com) gel or Matrigel
(BD Bioscience) resting on a polycarbonate filter and floating in
serum-free medium (supplemental online Fig. 2).
Reverse-Transcriptase Profiler Polymerase Chain
Reaction Array
Geneexpression insortedEPCPs (c-kit+dim/EpCAM+cells)werecom-
paredwith isolated c-kit2/EpCAM+ epithelial cells. RNAwas isolated
byusingaRNeasyMini kit (catalogno.74104;SABiosciences,Qiagen,
Valencia, CA, http://www.qiagen.com); cDNAwasmade by using an
RT2FirstStrandKit (catalogno.330401; SABiosciences,Qiagen)and
applied to the Mouse Stem Cell Transcription Factors RT2 Profiler
Array (Qiagen, PAMM-501Z). Quantitative reverse-transcriptase po-
lymerase chain reaction was performed on the ABI 7300 system
(Thermo Fisher), and data were analyzed by using online normaliza-
tion and analysis tools (provided in the public domain, http://
sabiosciences.com/pcrarraydataanalysis.php). Three independent
experiments were performed.
In Vitro Colony-Forming Efficiency Assay
Colony-forming efficiency (CFE) assays were performed by using
FACS-isolated EPCPs and c-kit2/EpCAM+ epithelial cells (control)
or EPCPs thatweremaintained in eithermonolayer or 3D cultures
for 3 weeks. Monolayer and 3D cultures were trypsinized to pre-
parea single cell solutionbeforeCFEassays.All cellswerewashed,
filtered, counted, and centrifuged in 15-ml tubes at 300g for
10 minutes. The supernatant was removed, and cells were resus-
pended in an appropriate volume of culture medium by gentle
pipetting to generate a single cell suspension as confirmed bymi-
croscopy. Cells were seeded at 13 103 cells per square centime-
ter into coated six-well dishes. The colonies were fixed at day 8
and stained with 10% methylene blue in 70% ethanol. The CFE
was calculated as the number of colonies at day 8 as a proportion
of the number of cells plated in a well. Colonies were manually
Gromova, Voronov, Yoshida et al. 3
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scoredunder a stereomicroscope. The standard error of themean
was calculated for at least three independent experiments and at
least three replicates for each experimental point.
Tear Production Measurement
Tear production wasmeasured by using phenol red-impregnated
cotton threads (Zone-Quick; Lacrimedics, DuPont, WA, http://
www.lacrimedics.com), as described previously [10, 20]. The
threads were applied to the ocular surface in the lateral canthus
for 10 seconds. Wetting of the thread (which turns red in contact
with tears) was measured in millimeters. Tear volume was mea-
sured in both eyes of recipient mice before and after progenitor
cell transplantations. Only females with reduced tear production
(2.5 6 0.5 mm) were used in transplantation experiments.
EPCP Cell Transplantation
Sorted EPCP cells were pelleted and resuspended inMinimumEs-
sential Medium a (a-MEM) (Corning). To analyze EPCP engraft-
ment, we performed EPCP transplantation into injured LGs. LGs
of 3- to 4-month-old WT recipient mice were injured by a single
IL-1 injection as described previously [10]. Donor EPCP cells were
obtainedby cell sorting fromuninjured LacZ+ LGs (see above) of 3-
to 4-month-oldWTmice andwere transplanted into the recipient
LGs1or3daysafter the injury. Approximately 4,000–5,000cells in
3 ml of a-MEM were slowly injected into the LG of anesthetized
mice by using a 28-G needle and a Microliter Syringe (Hamilton,
Reno, NV, http://www.hamiltoncompany.com). Control LGs were
injectedwith vehicle (a-MEM). Transplantationwas repeated for a
total of three independent experiments. Analysis of EPCP engraft-
ment was carried out 40 days after transplantation. To analyze en-
graftment and function of EPCPs in the chronically inflamed LG of
TSP-12/2mice,we isolated EPCP fromWTPax6-LacZ+donor LGs as
described above. Cells were injected into the LG of 6- to 8-month-
oldTSP-12/2mice. EvaluationofEPCPengraftmentwasperformed
at 20, 40, and 80 days after transplantation.
Lacrimal Gland X-Gal Staining
Donor LGs were fixed with 1.25% paraformaldehyde and 1.25% glu-
taraldehyde solution and processed for 5-bromo-4-chloro-3-indolyl
b-D-galactoside (X-Gal) staining as described previously [19].
Histology, Cell Quantification, and Evaluation of
Cell Engraftment
Analysis of Cell Engraftment in IL-1a Injured LG
LGs stained with X-Gal were embedded in paraffin, and 5- to
10-mm sections were costained with Fast Red to visualize the nu-
clei. Slideswere scannedwith a Leica scanner (LeicaMicrosystems,
Wetzlar, Germany, http://www.leica-microsystems.com). To de-
termine the efficiency of recipient cell engraftment after LG acute
injury with IL-1a, the number of LacZ+ and LacZ2 cells were
counted on serial LG sections, and engraftment was estimated
byquantification of the ratio between LacZ+ and LacZ2 cells. Cells
were counted within the fields of 200 mm2 (8 fields per section, 15
sections per lacrimal gland, and 8 LGs per each time point were
analyzed}. Three independent experiments were performed.
Analysis of Cell Engraftment in TSP-12/2 LG
To evaluate cell engraftment into “diseased” LGs of the TSP-12/2
recipient mice, LGs were isolated at different time points (20, 40,
60, and 80 days) after EPCP transplantation, fixed, and processed
for X-gal staining. Serial paraffin sections (5mm in thickness) were
prepared from recipient and control (vehicle-injected) LGs and
stainedwithFastRed tovisualizenuclei. Every third sectionwascol-
lected for further analysis. Engraftment was assessed as the per-
cent of LacZ+ donor-derived cells in each injected LG lobe. Cells
were counted in 200-mm2 fields, with 8 fields per section and 15
sections per LG. Four LGs were assessed at each time point in each
of three independent experiments (i.e., in total 12 LGs [180 sec-
tions] were analyzed per time point). Quantification andmeasure-
ment of inflammatory foci were performed by using a Leica DM4B
microscope and LAS X integrated imaging system.
Statistical Analysis and Data Presentation
Statistical analyses were performed by using Prism Software
(GraphPad, San Diego, CA, http://www.graphpad.com). In bar
graphs, data are presented as means 6 SD of replicates from a
representative experiment or of thenormalizeddata fromseveral
experiments. In the latter case, mean fold changes were calcu-
lated by first determining the ratio of the test condition over
the appropriate control condition for each individual measure-
ment, and then averaging these ratios. The unpaired two-tailed
Student’s t test and two-tailed Fisher’s exact test were used to de-
terminesignificance (p, .05) in thedifferencesbetweendata sets.
RESULTS
Isolation of Putative LG EPCPs by Fluorescence-
Activated Cell Sorting
We selected a panel of potential markers for LG progenitor cells
based on existing publications. CD-117, also known as c-kit, is the
receptor for stem cell factor, a cytokine involved in stimulating a
variety of stem cells to cycle. Although c-kit was originally de-
scribed on hematopoietic stem cells, this receptor is found on nu-
merous stem cell types [21–25]. c-kit+ cells restored function of
irradiated salivary glands [26] and regenerated the prostate gland
[27].Weassessedthedistributionofc-kit+cellsby immunostainingof
wholeLGs (Fig.1A,1B)using thec-kitantibody.At least threetypesof
c-kit+ cells were observed: small and large bright granular cells were
scattered throughout the mesenchyme (Fig. 1A, 1B, large arrow-
heads), and small dim c-kit+ cells were seen in the epithelium (Fig.
1A, 1B small arrowheads).
To distinguish between epithelial and mesenchymal c-kit+
cells, we used EpCAM. EpCAM is reported to mark undifferenti-
ated and differentiated epithelial cells in multiple glandular tis-
sues. Immunostaining of embryonic and adult LGs with the
EpCAM antibody (Fig. 1C, 1D) confirmed that EpCAM expression
was restricted to the LG epithelial cell lineage.
Similar to our immunostaining results, c-kit+dim and
c-kit+bright cells were evident by flow cytometry (Fig. 1E–1G;
supplemental online Fig. 2C). The EpCAMantibodydetecteda sin-
gle population of EpCAM+ cells (Fig. 1H–1J; supplemental online
Fig. 2D).The isotype control antibodies showed no staining (Fig.
1G, 1J). We also used antibodies to stem cell antigen 1 (Sca1)
(expressed in multiple stem/progenitor cells), CD34 (hematopoi-
etic andmesenchymal progenitor cell antigen), and CD45 (hema-
topoietic cell marker). In separate experiments, we also tested
the antibody to CD31 (platelet endothelial cell adhesion mole-
cule). The last threemarkers were used to excludemesenchymal,
hematopoietic, and endothelial cells. Once conditions for specific
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staining with a single antibody were determined (supplemental
online Fig. 2C–2H), we used combinations of antibodies for flow
cytometry analysis. All cells in the c-kit+bright populations were
EpCAM2, but CD45+ (Fig. 1K). Thus, c-kit+bright cells have a non-
epithelial origin and could represent hematopoietic/endothelial
progenitors and possibly mast cells. Analysis of c-kit+dim cells
(Fig. 1L) with EpCAM and CD45 antibodies revealed three popu-
lations: c-kit+dim/EpCAM+/CD452 (22%, or 2.5%–3.0% of total
cells; red square), c-kit+dim/EpCAM2/CD45+ (70% or 8% of total
cells; green square), and small c-kit+dim/EpCAM2/CD452 (Fig. 1L;
,1% of total cells; yellow square). Further analysis of these cells
(Fig. 1M) using Sca1 and CD34 antibodies revealed that the only
epithelial (EpCAM+) cell populationwasnegative for bothof these
markers (i.e., c-kit+dim/EpCAM+/CD452/CD342/Sca12 [2.2%–2.7%
of total cells]) (Fig. 1M, red square). This cell population was also
CD31-negative (data not shown). We hypothesized that c-kit+dim/
EpCAM+/CD452/CD342/Sca12 cells represent a putative LG EPCP
population.
FACS-Isolated EPCP Cells Express Runx1 and the
Pluripotency Factor Oct4
To further characterize EPCPs, we compared sorted EPCPs
(c-kit+dim/EpCAM+/CD452/CD342/Sca12) with c-kit2 epi-
thelial cells (comprised of partially differentiated and differenti-
ated cells) (c-kit2/EpCAM+/CD452) for expression of stem cell
transcription factors using the StemCell Transcription Factor Array
(Qiagen). We found that EPCPs were highly enriched for pluripo-
tency factor octamer-binding transcription factor 4 (Oct4: 5.8-fold
increase;p= .004165), alsoknownasPOU5F1(POUdomain, class5,
transcription factor 1). Oct4 is frequently used as a marker for un-
differentiated cells and is critically involved in the self-renewal of
epithelial stemcells [28, 29].Oct4 is alsooneof the reprogramming
factors that allows somatic cells to be converted to induced plurip-
otent stemcells [30, 31]. In addition, putative EPCPsalsoexpressed
high levels of Runt-related transcription factor 1 (also known as
acute myeloid leukemia 1 protein or core-binding factor subunit
a-2) (3.6-fold; p = .000327) and vitamin D receptor (Vdr) (3.2-fold;
Figure 1. Characterization and isolation of c-kit- and EpCAM-positive cells. (A, B): c-kit expression (red) in embryonic (A) and adult (B) lacrimal
gland (LG). (C, D): EpCam expression (red) in embryonic (C) and adult (D) LG. Large c-kit+bright cells are seen in the mesenchyme (large arrow-
heads) and small c-kit+dim cells (small arrowheads) in the epithelium (blue indicates DAPI-stained nuclei). (E–G): Flow cytometric profile of
freshly isolated c-kit+ LG cells (E), gating of c-kit+bright and c-kit+dim cells (F), and isotype control antibody staining shows no labeled cells
(G). (H, I): Gating of LG EpCAM+ cells (H, I: red square in H and red peak in I are EpCAM2 cells; blue square in H and blue peak in I are EpCAM+
cells). (J): Isotype control antibody staining showsno labeled cells (blue square). (K):Gating the c-kit+bright cells: all c-kit+bright cells are EpCAM-/
CD45+ (blue square). (L): Gating of c-kit+dim/EpCAM+/CD45- cells. C-kit+dim events: red square, c-kit+dim/EpCAM+/CD452 cells, 22%; green
square, kit+dim/EpCAM2/CD45+ cells, 70%; yellow square, kit+dim/EpCAM2/CD452 cells, less than 8%. (M): Gating and isolation of epithelial
progenitor cell (EPCP) (c-kit+dim/EpCAM+/CD452 /CD342/Sca12 red square). (N):Putative EPCPs express stemcellmarkers. Geneexpression in
sorted EPCPs (c-kit+dim/EpCAM+ cells) were compared with isolated c-kit2/EpCAM+ epithelial cells using a RT2 First Strand Kit (catalog no.
330401; SABiosciences, Qiagen) and applied to TheMouse Stem Cell Transcription Factors RT2 Profiler Array. Only genes changed 1.5-fold with
significantly different expression levels (p, .01) are shown. Statistical analysis was performed by using real-time polymerase chain reaction
data fromthree independent RNApreparations. Abbreviations: DAPI, 49,6-diamidino-2-phenylindole; EpCAM,epithelial cell adhesionmolecule;
FSC-W, forward scatter pulse width.
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p = .002419) (Fig. 1N). Vitamin Dmetabolism has been reported to
modulate expression of pluripotency genes and cell differentiation
[32].ExpressionofPax6wasmoderately increased inEPCPs relative
to epithelial EpCAM+/c-kit2 cells (∼1.5-fold, p = .001344), whereas
the expression levels of Sox9 and Sox6, previously found to be im-
portant during LGgrowth in embryonic development [19, 33], are
equivalent in EPCP and the EpCAM+/c-kit2 cells (data not
shown). The expression of forkhead box protein A1, which plays
a critical role during embryonic development and tissue differenti-
ation [34–36], was moderately lower in EPCP than in EpCAM+/
c-kit2 cells (21.5-fold;p= .010214). Thesedatagive further support
to the hypothesis that isolated c-kit+dim/EpCAM+/CD452/CD342/
Sca12 cells are LG epithelial cell progenitors.
Establishment of Mouse Epithelial Cell Progenitor
Cultures With the Ability to Differentiate Into
Secretory Cells
We previously showed that Pax6 is expressed during LG develop-
ment in proliferating epithelial cells [18]. When plated, EPCPs
formed small aggregates adherent to the substrate that showed
multiple cell divisions. A subset of cellswithin eachprimary aggre-
gate expressed Pax6 (Fig. 2A, green). In 5–7 days, the aggregates
increased in size substantially, continued to express Pax6 (Fig. 2B,
green), and also started to express other epithelial markers, such
as E-cadherin (Fig. 2B, red). In 2 weeks, the proportion of cells
expressing Pax6 increased further (Fig. 2C, green), and in 3weeks,
the cells spread throughout the plate (Fig. 2D, green). This in-
creasing proportion of Pax6+ cells is consistent with recent find-
ings that in epithelium, Pax6marks a highly proliferativepopulation
of committed transit amplifying progenitors [37–39].
Next, we studiedwhether EPCPs could differentiate in culture.
Replacement of growthmediumwithdifferentiationmedium (me-
dium with low EGF and bFGF content) induced differentiation as
shownbyWesternblotanalysisof thespecificacinardifferentiation
marker Aqp5 (Fig. 2E, 2F). We found that EPCPs cultured for 2–4
days had low levels of Aqp5 expression, whereas cells cultured
for 7–14 days had relatively elevated Aqp5 expression (Fig. 2E,
2F). These findingssuggest that isolatedEPCPscontainproliferating
progenitor cells that can differentiate into secretory cells.
Reaggregated Cultures Preserve Colony-Forming
Capability of EPCPs
LG-derived cell cultures show a decrease in cell proliferation over
time, suggesting that themonolayer cultures donot support long-
term progenitor cell survival/expansion. The cells within the in-
tact LG are organized into three-dimensional (3D) structures
[40, 41]. This 3D organization is critical for normal lung, cartilage,
mammary gland, and many other organ progenitor cell functions
[42–44]. We developed a simple and efficient technique for 3D
culture of LG-derived EPCPs, which allowed enzymatically disag-
gregated EPCPs to regain cell-cell contacts by reaggregation
(supplemental online Fig. 1). FACS-sorted EPCPswere dissociated
in 50 ml of growth medium and drawn into a pipette tip, and the
tip was sealedwith parafilm. Cells were than pelleted, and the re-
aggregate was inoculated into a 15-ml drop of laminin-111 (Tre-
vigen) gel or Matrigel (BD Bioscience) on a polycarbonate filter
floating in growth medium. We reasoned that complex cell-cell
and cell-matrix interactions in combination with growth factors
might preserve the progenitor cell properties of EPCPs.Wemain-
tained these3Dcultures inparallelwithmonolayer control cultures
for 3 weeks and then dissociated and seeded cells into six-well
plates for in vitro colony-forming efficiency assays. Freshly isolated
EPCPs were used as an additional control. The colonies were
countedat day8, andCFEwas calculated as the numberof colonies
as of day 8 as a proportion of the number of cells plated (Materials
andMethods). Both freshly isolated LG cells and the cells obtained
fromthe3Dcultures formed five timesmore colonies (as apercent-
age of cells plated) than cells obtained from monolayer cultures
(monolayer cultures = 1.09%6 0.5%; p = .010241; freshly isolated
cells = 5.586 1.11%, p = .001524; 3D cultures = 5.07%6 0.89%,
p = .005212) (Fig. 2G). This experiment showed that reaggregated
3Dculturesareable topreserve theprogenitorpropertiesofEPCPs.
Moreover, we testedwhether cellular reaggregates could dif-
ferentiate into branched structures in differentiation medium
supplementedwith FGF10.We found that reaggregatedEPCP cul-
tures formed primary buds in 48–72 hours (Fig. 2H), and these
buds expressedepithelialmarker E-cadherin and stemcellmarker
Krt5 [19] (Fig. 2I). Moreover, in 7–10 days these cultures formed
well-distinguishedductal andacinar components (Fig. 2J, 2K). This
finding suggests that FACS-isolated EPCPs represent a progenitor
cell population capable of undergoing branchingmorphogenesis.
Putative EPCPs Engraft Into Injured and “Diseased” LGs
To test the ability of EPCPs to engraft into injured LGs, we per-
formed direct intraglandular transplantation of sorted EPCPs
obtained from Pax6-LacZmice [18, 45] into LGs of nontransgenic
recipients (both recipient and donor mouse colonies had the
same C57BL/6 genetic background). Before cell transplantation,
the recipient LG was injured by IL-1a injection [10], and sorted
EPCPs were transplanted at 1 day (Fig. 3A, 3B) or 3 days (Fig.
3C, 3D) after the injury. Analysis of cell engraftment was carried
out at 40 days after cell transplantation. In both cases (1 and
3 days after the injury), EPCPs injected into the LG were found in
the ductal (Fig. 3A, 3B, 3D, black arrows) and acinar epithelial com-
partment (Fig. 3A–3D, white arrowheads). Control LGs injected
with the vehicle did not show any LacZ+ cells (Fig. 3E). Interestingly,
EPCPs transplanted into uninjured LGs showed no or minimal en-
graftment (data not shown). Moreover, cells injected 3 days after
the injury (at thebeginningof theLGregenerationphase)engrafted
moreefficiently (7.51%60.73%,p, .001) than cells injected1day
after LG injury (LG damage/inflammation phase) (1.43%6 0.07%;
p, .001) (Fig. 3F). Thus, putative EPCPs were able to engraft into
the LG epithelial compartment, and the efficacy of engraftment
depended on the phase of LG regeneration.
Next,we studiedwhether EPCPs could restore “diseased” LGs
of the recently reported and relatively new model of ADDE—the
TSP-12/2 mouse. Similar to SjS patients, SjS-specific autoanti-
bodies were detected at elevated levels in the TSP-12/2 mice
sera. TSP-12/2 mice also have elevated levels of interleukins
and IFN-g, and, importantly, they gradually develop severe in-
flammation of the LGwith infiltrates containing CD4 and CD8 cells,
similar to humanswith SjS [14, 46, 47]. Analysis of Tsp-1 expression
pattern in the LGshowedthat Tsp-1protein is expressedattheapical
surface of ductal epithelial cells (supplemental online Fig. 3A, 3B; white
arrows) and in the elongated cells surrounding secretory acini
(supplemental online Fig. 3A, 3B). This pattern of Tsp-1 expression
suggests that, in addition to the ductal cells, Tsp-1 may be found in
the endothelial or myoepithelial cells. Coimmunostaining with the
platelet endothelial cell adhesionmolecule-1 (blood vesselmarker)
antibody showed that Tsp-1 was not expressed in the small blood
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vessels (supplemental online Fig. 3C, 3D, red arrows), but was
found in the external layer of cells (most likelypericytes) surrounding
large blood vessels (supplemental online Fig. 3D, white arrowhead).
Coimmunostaining with the a-smooth muscle actin (marker of
myoepithelial cells) antibody showed that Tsp-1 was expressed
in all myoepithelial cells (supplemental online Fig. 3E, 3F, yellow
arrows).
Analysis of TSP-12/2 mouse LGs showed that inflammation
starts at approximately 10–12 weeks as periductal lymphocytic
infiltrates (Fig. 3, compare 3G and 3H; lymphocytic infiltrates
are marked by black arrows), with severe inflammation and for-
mation of large lymphocytic infiltrates evident by 6–8 months of
age (Fig. 3; compare Fig. 3G and 3H). We wished to examine
whether stem cell treatment could benefit advanced cases of
dry eye disease and, in particular, whether donor cells could en-
graft and differentiate in these conditions. Hence, we used
8-month-old TSP-12/2 female recipient mice with advanced LG
inflammation. The recipient mice were chosen based on tear se-
cretion level: only TSP-12/2 mice with significantly decreased
(2.56 0.5mm) aqueous tear productionwere used (tear produc-
tion was measured by using phenol-impregnated cotton threads
as described in Materials and Methods). Sorted EPCPs obtained
from Pax6-LacZmicewere injected into recipient LGs on one side,
whereas the contralateral LG was injected with vehicle as a con-
trol. Analysis of cell engraftment and LG morphology was per-
formed at 20, 40, 60, and 80 days after EPCP transplantation
(12 recipient TSP-12/2 female mice per each time point were
used in three independent experiments) (Fig. 3K–3O). At 20 days
after transplant, LacZ-positive EPCPs were mostly incorporated
into LG ducts (Fig. 3K); at 40 days after transplant, EPCPs were
found in the ducts and differentiating LG acini (Fig. 3L). At
60–80 days after transplant, LacZ-positive cells were present in
the ducts and acini (Fig. 3M, 3N). Comparison of stem cell-
injectedand control (saline-injected) LGmorphology showed that
density and size of LG inflammatory foci progressively decreased
in EPCP cell-injected LGs, whereas density and size of foci in con-
trol LGs remained unchanged (compare Fig. 3K-3N with 3O).
Quantification of cell engraftment at 40 and 80 days after trans-
plant indicated stable long-term donor engraftment (Fig. 4A). At
these stages, we observed a strong reduction in lymphatic cell in-
filtrations; we also observed the differentiation of LacZ-positive
cells into secretory acini (Figs. 3M, 3N, 4B). We compared num-
bers and sizes of infiltration foci in LG injected with EPCPs (40
and 80 days after transplant) or with saline using a two-tailed t
Figure 2. Differentiationof lacrimal gland (LG)epithelial cells inmonolayer culture. (A–D):Oneday (A), 1week (B,C), and3weeks (D). (A–D):Cultured
cells were stained with antibody to Pax6 (green). (B): Cells were stained with antibodies to Pax6 (green) and E-Cadherin (red). Nuclei are stained with
DAPI (blue). (E):Westernblotshowingexpressionofaquaporin-5(Aqp5) in fluorescence-activatedcell sorting-isolatedepithelialprogenitorcells (EPCPs)
cultured for 2, 4, 7, and 14days. (F):Quantification of protein abundance asmeasured from immunoblot band intensities (e.g., E) in three independent
experiments. Values represent the optical density of Aqp5 bands normalized to that of b-actin bands (means of three experiments6 SD). (G): Com-
parison of colony forming abilities (using an in vitro colony forming efficiency [CFE] assay) of EPCPs grown in monolayer, freshly isolated EPCPs, and
EPCPsgrown in three-dimensional (3D) reaggregated cultures. TheCFEwas calculatedas thenumberof colonies atday8as aproportionof thenumber
of cells plated in a well. In each experiment, six replicate wells were analyzed per each experimental condition. The final CFE was calculated in three
independent experiments (i.e., a total of 18wells per each condition).p valuewasdeterminedversus control (freshly isolatedEPCPs). Asterisk indicates
significant differences between monolayer cultures and freshly isolated or reaggregated cultures: *, p, .01. (H): EPCPs grown in 3D reaggregated
culture formbuds in 24–48 hours. (I): Buds express Krt5 (green) and E-cadherin (red). (J): LG reaggregates cultured for 1week differentiate into ductal
and acinar components. (K): Transverse section of one of the acinar components of the 3D reaggregated culture showing acinar structure. Sectionwas
stained with Fast red to visualize nuclei. Abbreviations: ac, acinar; DAPI, 49,6-diamidino-2-phenylindole; duct, ductal; E-cad, E-cadherin.
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test. (Fig. 4B), revealing a significant reduction in inflammation in
TSP-12/2 LGs after EPCP transplantation. We also calculated the
statistical significance of the differences in the number of large
(.100 mm) and small (,100 mm) foci in experimental (40 and
80 days after EPCP cell transplantation) and control (saline-
injected) LGs using a two-tailed Fisher’s exact test. The numbers
of large and small foci in saline- and EPCP-injected (40 days after
transplantation) LGs differed, with p , .0001; saline- and EPCP-
injected(80daysaftertransplantation)differedwithp, .0001.Com-
parison of numbers of foci in the LGof EPCP-injectedmice at 40 days
versus 80 days after transplantation showed a significant difference,
with p , .03. In addition, the cumulative area of inflammation
(summed area of infiltration foci, measured in square micrometers)
in these two EPCP-injected groups (40 and 80 days after transplan-
tation) was compared with control saline-injected LGs. We found
that EPCP-treated LGs had substantial reduction of cumulative area
of inflammation (Fig. 4C). These tests indicate significant progressive
improvement of the “diseased” LG structure, particularly reduction
in inflammatory foci, up to 80 days after EPCP transplantations.
EPCP Cell Transplantation Improves LG Function
We performed functional assessment of the tear production us-
ing phenol-red-stained cotton threads (Zone-Quick; Oasis Medi-
cal, Glendora, CA, http://oasismedical.com) as we described
previously [14]. Estimation of tear production was performed
at 0, 2, 4, 6, and 8 weeks after EPCP transplantation (Fig. 4D)
and compared with tear production in control saline-injected
LGs. At least six female mice per each time point and each treat-
ment condition were used in each experiment, and the experi-
ment was repeated three times. The two-tailed Fisher’s exact
test was used to identify significant differences between the
mean values of experimental and control groups for each time
point. This test showed significant differences in tear production
Figure 3. Epithelial progenitor cell (EPCP) transplantation inmodelsofacuteandchronic lacrimal gland (LG) inflammation. (A–D):DonorEPCPs (LacZ+)
injected into host LG 1 day (A, B) and 3 days (C, D) after the interleukin-1a injury engraft into the recipient’s LGs. LG were analyzed 40 days after the
transplantation. LacZ+ cells are found inacinar (white arrowheads) andductal compartments (black arrowheads). (E):Control (injectedwith thevehicle)
showsnoLacZcells.All sectionsarecostainedwithFastRedtovisualizenuclei. (F):QuantificationofEPCPengraftment intorecipient’s injuredLG40days
afterEPCPcell transplantation.Engraftmentofcells injected3daysafter the injury ismoreefficientthanengraftmentofcells transplanted1dayafterthe
injury. Engraftment was determined as a percent of the ratio between LacZ+ and LacZ2 cells. Eight LGs per each time point were analyzed in three
independent experiments. Asterisk indicates significant differences in cell engraftment between transplantations performed on days 1 and 3 after
LG injury; *, p, .05. (G–J): TSP-12/2mice progressively develop a severe inflammation in the LG. LG of 3-month-old (G) and 8-month-old (I)WTmice
show normal acinar structure, whereas the LG of 3-month-old TSP-12/2mice show numerous periductal cell infiltrates (H, black arrows) and by 8
monthsTSP-12/2micedevelopsevere LG inflammation (J, black arrows indicate large inflammation foci). (G,H):H&E is shown. (I, J):Trichromestaining
is shown. (K–O):Engraftmentof LacZ+ EPCPs into chronically inflamedLGof 8-month-oldTSP-12/2mice: analysis of cell engraftmentwasperformed20
(K), 40 (L), 60 (M), and 80 (N) days after cell transplantation. (O): Negative control, saline-injected LG. Abbreviation: WT, wild-type.
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between EPCP- and saline-injected (control) TSP-12/2 mice at 6
and 8 weeks after cell transplantation (Fig. 4D). Comparison of
saline-injected mice at 0- and 8-week time points showed no dif-
ference in tear production (p = .27),whereas comparison of EPCP-
injected mice at 0- and 8-week time points showed a significant
difference (increase) in tear production (p = .0002). The results
suggest a significant progressive improvement of LG function af-
ter EPCP transplantation in an LG disease model.
DISCUSSION
Our studies suggest that mouse LG contains at least one putative
EPCP (c-kit+dim/EpCAM2/CD452/CD342/Sca12) population
that is able to engraft into the epithelial (acinar and ductal) com-
ponent of injured/regenerating or “diseased” LG and restore LG
structure and function. The c-kit receptor has been reported to
mark epithelial progenitor-like cells during development of other
glands, such as prostate and submandibular gland [27, 48]. During
submandibular gland morphogenesis, highly proliferative distal
buds contain progenitors expressing the c-kit receptor, which is
critical for maintenance and expansion of small mucous granule
embryonic progenitor cells [49]. Our study shows that the c-kit
receptor is an important marker that identifies adult stem/
progenitor cells in LG epithelium. We showed that isolated LG
EPCPs possess several important properties of stem/progenitor
cells. EPCPs showelevated expressionof stemcellmarkers Runx1,
Oct4, Pax6, andVdr; formcolonies; anddevelop into LGorganoids
that differentiate into ductal and secretory compartments in 3D
cultures. The important role of Pax6 for ocular progenitor cell
function was reported in numerous publications [39, 50–56]. It
has been reported that Oct4 is critical for self-renewal and main-
tenance of multiple stem and progenitor cell types, and Oct4 is
downregulated in all differentiated somatic cell types in vitro
and in vivo [57, 58]. In the corneal epithelium, Oct4+ cells were
Figure4. EPCP transplantation improves lacrimal gland (LG) structure and function. (A):Analysis of EPCP engraftment into “diseased” LGof
8-month-old TSP-12/2mice 40 and 80 days after cell transplantation. A total of 180 sections from 12 EPCP-injected and 12 control LGs were
analyzed per each time point. (B): Transplantation of EPCPs decreases inflammation of host (8-month-old TSP-12/2) LG with advanced stage
aqueous-deficiency dry eye. The data are mean number of inflammatory foci6 SD from four or five mice. Statistical significance of differences
between groups was calculated by using a two-tailed t test for groups with unequal variance and gave the following p values: saline-injected
versus EPCP-injected (60 days after injection), p = 1.05658530891 3 108; saline-injected versus EPCP-injected (80 days after injection),
p = 2.53814392935 3 1014; EPCP-injected (60 days after injection) versus EPCP-injected (80 days after injection), p = 7.56001815449 3
1011. (C): Total area of inflammation (cumulative foci [mm2]) in TSP-12/2mouse LG decreases after EPCP transplantation (area of inflammation
was calculated at 40 and 80 days after EPCP transplantation in three independent experiments, with four animals per condition in each exper-
iment). In all experiments shown inA–C, 180 sections from12 EPCP-injected and 180 sections from12 control saline-injected LGswere analyzed
per each time point. Asterisks indicate significant differences in size of area of inflammation (measured in mm2) between saline- and EPCP-
injected LGs; *, p , .05. (D): Animals (8-month-old TSP-12/2 mice) that received a single injection of EPCPs showed a significant increase
in tear production at 4 weeks after transplantation. Tear production was measured in 18 mice per each time point and each condition in three
independent experiments (six mice per experiment). The two-tailed Fisher’s exact test was used to identify significant differences between the
mean values of experimental and control groups for each time point. The p values for each time point were as follows: 0 weeks (p = 1), 2 weeks
(p=1), 4weeks (p= .06), 6weeks (p= .0002), and8weeks (p= .002). Asterisks indicate differences in tear productionbetweenday0andweeks 4,
5, and 6 after EPCP transplantations; *, p values are determined in the text above. Abbreviation: EPCPs, epithelial progenitor cells.
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mainly found in limbal and central corneal epithelial basal layers
[57]. These reports are consistent with our data showing that, in
contrast to EPCPs, differentiated epithelial cells of the LG have no
or very little Oct4 expression. Enriched expression of the Runx1
transcription factor was also detected in isolated EPCPs. Runx1
is involved in stem cell specification, proliferation, and differen-
tiation in various tissues [59–61], and it influences tissue differen-
tiation andhomeostasis [60].Wepreviously showed that Runx1 is
a marker of the LG epithelial (ductal and acinar) cell lineage [19,
62] during LG development and that Runx1 expression strongly
increased during adult LG regeneration [19]. We also show that
FACS-isolated EPCPs engraft only into epithelial but not the mes-
enchymal compartment of the LG, consistentwith our hypothesis
that EPCPs are epithelial lineage specific stem/progenitor cells.
In the LG acute injury model, transplanted EPCPs engrafted
differently depending on the timing of transplantation after in-
jury. The most efficient donor cell engraftment was observed
when EPCPs were transplanted 3 days after injury, and they were
less efficient at 1 day after injury. Zoukhri et al. previously report-
ed that the most extensive inflammatory response in the IL-1a-
injured LG was observed on the first and second day after injury,
whereas LG remodeling/regeneration was most evident on day
three after injury [10]. Thus, the state of the host LG is important
for successful donor cell engraftment, and the latter ismost efficient
once inflammation has subsided and regeneration has begun. These
findings could inform the development of successful LG repair strat-
egiesusing stem/progenitor cells, and, inparticular, they suggest that
suppression of ongoing inflammatory processesmay increase the ef-
fectiveness of stem cell treatments in chronically “diseased” LGs.
Importantly, we showed for the first time that intraglandular
transplantation of EPCPs could restore structure and function of
the chronically “diseased” TSP12/2 LG. We recently showed that
expressionof important epithelial stem/progenitor cellmarkers is
altered in the LGs of two mouse models of Sjo¨gren’s syndrome:
nonobese diabetic andMRL-lpr/lprmice during LG inflammation
[63]. This finding suggests the importance of the LG state for stem
progenitor cell function and the possible role of inflammation in
suppressing regeneration. However, our presentwork shows that
EPCP transplantation was effective, even for older mouse recip-
ients with advanced LG inflammation. Transplanted cells were
able to not only engraft into LG epithelial compartment, but also
to partially restore the structural integrity of the LG acini and im-
prove secretory function. We observed that, even in the areas
with low numbers of the engrafted EPCPs, the density of infiltrat-
ing cells within the inflammatory foci decreased. We speculate
that, as described for some other stem/progenitor cells [64,
65], EPCPs might produce anti-inflammatory factors that reduce
immune cell infiltration. These findings are promising for the de-
velopment of stem cell therapies to treat LG diseases.
Overall, our study shows that uninjured adult LGs contain ep-
ithelial cell progenitors that we define as EPCPs. These EPCP cells
could successfully engraft intoductal and acinar compartments of
“diseased” LGs and restore acinar structure. We also found that
EPCPs could increase tear secretion in TSP-12/2mice with chronic
LG dysfunction. Our work provides an important first step toward
identifyingandcharacterizinganepithelial-specific progenitorpop-
ulation able to restore function in the LG. Further analysis of the
molecular mechanisms that define and regulate their function
within normal and “diseased” LGs could facilitate development
of new cell-based treatments for dry eye and other LG conditions.
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